cjc-1295 and ipamorelin. Cjc + Ipamorelin CJC 1295 & Ipamorelin Benefits, Uses, Safety Sleep & Sculpt Peptide Therapy

Lage et al., 2022)

One treatment that continues to attract attention is peptide therapy with CJC-1295 and Ipamorelin

Isocitric acid is further converted to ketoglutarate under the action of isocitrate dehydrogenase (IDH)

doi: 10.1007/s11095-011-0500-z

The results were consistent: Trunk fat reduction: Tesamorelin-treated patients showed statistically significant reductions in trunk fat versus placebo at 26 weeks.[1] VAT reduction: Using cross-sectional CT imaging, tesamorelin produced approximately 1520% reductions in visceral adipose tissue compared to placebo.[1,2] Triglyceride improvement: Alongside fat reduction, tesamorelin improved triglyceride levels a key marker in metabolic syndrome.[2] Tesamorelin IGF-1 elevation: Treatment reliably elevated IGF-1 levels toward age-appropriate norms, confirming successful GH-axis stimulation.[1] These reductions occurred without dietary caloric restriction being mandated